Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-04-26 00:17 | 2016-04-21 | UAL | United Airlines Holdings, Inc. | PAR INVESTMENT PARTNERS LP | Director | Air Transportation, Scheduled | BUY | $52.10 | 1,905,000 | $99,251,643 | 16,294,711 | +13.2% |
| 2016-04-22 23:18 | 2016-03-22 | RHNO | N/A | Royal Energy Resources, Inc. | 10% owner | Other | BUY | $0.15 | 60,000,000 | $9,000,000 | 66,769,112 | +886.4% |
| 2016-04-23 00:33 | 2016-04-20 | NXCN | N/A | Havanti AS | 10% owner | Other | BUY | $77,170.00 | 7,716,958 | $595,517,648,860 | 8,757,796 | +741.4% |
| 2016-04-22 23:15 | 2016-04-22 | UAL | United Airlines Holdings, Inc. | MUNOZ OSCAR | Director, Officer - President and CEO | Air Transportation, Scheduled | BUY | $50.53 | 19,800 | $1,000,494 | 163,675 | +13.8% |
| 2016-04-21 19:43 | 2016-04-19 | ERC | ALLSPRING MULTI-SECTOR INCOME FUND | Saba Capital Management, L.P. | 10% owner | Other | BUY | $12.29 | 177,110 | $2,177,107 | 5,732,425 | +3.2% |
| 2016-04-22 00:31 | 2016-04-21 | EXAD | N/A | Baron Capital Enterrpise Inc. | Other | Other | BUY | $40,000.00 | 55,000,000 | $2,200,000,000,000 | 61,000,000 | +916.7% |
| 2016-04-20 00:10 | 2015-12-29 | SNEY | N/A | HALE GARRETT | Director, Officer - PRESIDENT/CEO | Other | BUY | $950.68 | 8,027,900 | $7,631,999,295 | 32,433,733 | +32.9% |
| 2016-04-19 00:57 | 2016-04-14 | SMLP | N/A | ENERGY CAPITAL PARTNERS II, LLC | Director, 10% owner | Other | BUY | $18.25 | 59,974 | $1,094,645 | 5,357,077 | +1.1% |
| 2016-04-15 01:41 | 2016-04-12 | AGLE | Spyre Therapeutics, Inc. | LILLY ELI & CO | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 500,000 | $5,000,000 | 2,568,543 | +24.2% |
| 2016-04-15 01:02 | 2016-04-13 | TNGO | N/A | Clearlake Capital Partners IV Finance, L.P. | 10% owner | Other | BUY | $7.25 | 1,202,666 | $8,719,329 | 7,492,797 | +19.1% |
| 2016-04-14 00:42 | 2016-04-11 | MFRM | N/A | Berkshire Partners Holdings LLC | 10% owner | Other | BUY | $41.44 | 74,008 | $3,067,069 | 25,769 | +100.0% |
| 2016-04-14 04:59 | 2016-04-11 | WLH | N/A | GMT CAPITAL CORP | 10% owner | Other | BUY | $14.27 | 72,700 | $1,037,429 | 4,126,817 | +1.8% |
| 2016-04-13 00:17 | - | CTXR | Citius Pharmaceuticals, Inc. | Mazur Leonard L | Director | Pharmaceutical Preparations | BUY | $0.60 | 5,000,000 | $3,000,000 | 5,457,143 | +1,093.7% |
| 2016-04-12 23:52 | 2016-04-08 | CONN | N/A | STEPHENS HARRIET C | 10% owner | Other | BUY | $10.74 | 250,000 | $2,684,950 | 2,727,920 | +10.1% |
| 2016-04-12 23:53 | 2016-04-08 | CONN | N/A | STEPHENS WARREN A | 10% owner | Other | BUY | $10.74 | 250,000 | $2,684,950 | 2,727,920 | +10.1% |
| 2016-04-13 00:09 | 2016-04-12 | AGLE | Spyre Therapeutics, Inc. | Novartis Bioventures Ltd | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 300,000 | $3,000,000 | 2,310,924 | +14.9% |
| 2016-04-11 21:58 | 2016-04-07 | IBIO | iBio, Inc. | Eastern Capital LTD | 10% owner | Pharmaceutical Preparations | BUY | $0.62 | 6,500,000 | $4,043,000 | 33,744,000 | +23.9% |
| 2016-04-07 21:55 | 2016-04-05 | OMAG | N/A | Matus Alan M. | Director | Other | BUY | $25,000.00 | 27,778 | $694,450,000 | 91,240 | +43.8% |
| 2016-04-07 21:04 | 2016-04-06 | ISD | PGIM High Yield Bond Fund, Inc. | Sullivan James Joseph | Other | Other | BUY | $15.51 | 64,500 | $1,000,369 | 92,000 | +234.5% |
| 2016-04-08 00:11 | 2016-04-05 | N/A | N/A | SPH Manager, LLC | Director, 10% owner | Other | BUY | $13.50 | 279,961 | $3,779,474 | 5,549,300 | +5.3% |
| 2016-04-08 00:40 | 2016-04-07 | MFRM | N/A | Berkshire Partners Holdings LLC | 10% owner | Other | BUY | $41.85 | 33,533 | $1,403,383 | 24,975 | +100.0% |
| 2016-04-07 22:12 | 2016-04-05 | OMAG | N/A | Lombardo Louis J | Director | Other | BUY | $25,000.00 | 27,778 | $694,450,000 | 125,297 | +28.5% |
| 2016-04-08 00:35 | 2016-04-05 | MFRM | N/A | Berkshire Partners Holdings LLC | 10% owner | Other | BUY | $41.68 | 121,534 | $5,065,221 | 24,615 | +100.0% |
| 2016-04-07 21:41 | 2016-04-05 | OMAG | N/A | Drohan Frank J | Director, Officer, 10% owner - President & CEO | Other | BUY | $50,400.00 | 56,000 | $2,822,400,000 | 2,075,931 | +2.8% |
| 2016-04-07 22:04 | 2016-04-05 | OMAG | N/A | SMITH JACK A | Director | Other | BUY | $25,000.00 | 27,778 | $694,450,000 | 91,240 | +43.8% |
| 2016-04-06 23:32 | 2016-04-01 | TLP | N/A | Revers Daniel R | Director, 10% owner | Other | BUY | $35.50 | 3,166,704 | $112,417,992 | 3,166,704 | +100.0% |
| 2016-04-06 01:08 | 2016-04-01 | SMLP | N/A | ENERGY CAPITAL PARTNERS II, LLC | Director, 10% owner | Other | BUY | $16.04 | 183,115 | $2,937,146 | 5,187,229 | +3.7% |
| 2016-04-06 00:15 | 2016-04-01 | VTVT | vTv Therapeutics Inc. | PERELMAN RONALD O | 10% owner | Pharmaceutical Preparations | BUY | $5.20 | 400,000 | $2,079,960 | 2,390,666 | +20.1% |
| 2016-04-05 19:47 | 2016-04-04 | WLH | N/A | GMT CAPITAL CORP | 10% owner | Other | BUY | $14.27 | 172,725 | $2,464,786 | 4,054,117 | +4.5% |
| 2016-04-05 19:29 | 2016-03-31 | WLH | N/A | GMT CAPITAL CORP | 10% owner | Other | BUY | $14.21 | 982,894 | $13,966,924 | 3,881,392 | +33.9% |
| 2016-04-05 01:09 | 2016-04-04 | MFRM | N/A | Berkshire Partners Holdings LLC | 10% owner | Other | BUY | $42.42 | 78,960 | $3,349,625 | 23,309 | +100.0% |
| 2016-04-05 01:04 | 2016-03-31 | MFRM | N/A | Berkshire Partners Holdings LLC | 10% owner | Other | BUY | $42.49 | 25,174 | $1,069,764 | 22,764 | +100.0% |
| 2016-04-05 02:14 | 2016-03-31 | ITRI | ITRON, INC. | SCOPIA CAPITAL MANAGEMENT LP | 10% owner | Instruments For Meas & Testing of Electricity & Elec Signals | BUY | $41.81 | 62,710 | $2,621,987 | 4,525,084 | +1.4% |
| 2016-04-05 02:57 | 2016-03-31 | CWEI | N/A | ARES MANAGEMENT LLC | Director, 10% owner | Other | BUY | $8.80 | 287,000 | $2,524,509 | 287,000 | +100.0% |
| 2016-04-01 23:26 | 2016-03-30 | CONN | N/A | STEPHENS HARRIET C | 10% owner | Other | BUY | $12.35 | 250,000 | $3,088,475 | 2,477,920 | +11.2% |
| 2016-04-01 23:26 | 2016-03-30 | CONN | N/A | STEPHENS WARREN A | 10% owner | Other | BUY | $12.35 | 250,000 | $3,088,475 | 2,477,920 | +11.2% |
| 2016-04-01 23:21 | 2016-03-30 | ACAD | Acadia Pharmaceuticals Inc. | BAKER BROS. ADVISORS LP | Director, 10% owner | Pharmaceutical Preparations | BUY | $27.08 | 1,449,090 | $39,239,763 | 21,167,398 | +7.3% |
| 2016-04-01 00:41 | 2016-03-29 | NLN | N/A | LI NANCY | Director, Officer, 10% owner - Executive Vice Chairman | Other | BUY | $0.87 | 1,563,930 | $1,354,207 | 53,187,437 | +3.0% |
| 2016-04-01 00:01 | 2016-03-29 | AIMT | N/A | ENRIGHT PATRICK G | Director, 10% owner | Other | BUY | $13.87 | 78,504 | $1,089,133 | 7,513,134 | +1.1% |
| 2016-03-31 23:59 | 2016-03-29 | AIMT | N/A | Longitude Capital Partners II, LLC | 10% owner | Other | BUY | $13.87 | 78,504 | $1,089,133 | 7,513,134 | +1.1% |
| 2016-04-01 00:41 | 2016-03-29 | NLN | N/A | WANG CHARLES B | Director, 10% owner | Other | BUY | $0.87 | 1,563,930 | $1,354,207 | 14,575,791 | +12.0% |
| 2016-04-01 00:10 | 2016-03-29 | SHLD | N/A | FAIRHOLME CAPITAL MANAGEMENT LLC | Director, 10% owner | Other | BUY | $15.02 | 150,000 | $2,253,495 | 26,527,148 | +0.6% |
| 2016-03-31 01:17 | 2016-03-30 | MFRM | N/A | Berkshire Partners Holdings LLC | 10% owner | Other | BUY | $42.48 | 38,995 | $1,656,656 | 22,495 | +100.0% |
| 2016-03-30 20:07 | 2016-03-29 | CRVS | Corvus Pharmaceuticals, Inc. | Novo A/S | 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 666,666 | $9,999,990 | 3,154,046 | +26.8% |
| 2016-03-31 01:13 | 2016-03-28 | MFRM | N/A | Berkshire Partners Holdings LLC | 10% owner | Other | BUY | $41.71 | 195,421 | $8,150,560 | 22,079 | +100.0% |
| 2016-03-30 18:14 | 2016-03-28 | CSHB | N/A | Chandonnet Robert L | Director, 10% owner | Other | BUY | $2.30 | 550,291 | $1,265,834 | 613,921 | +864.8% |
| 2016-03-30 21:09 | 2016-03-28 | CSHB | N/A | Essex Bruce J | Director, 10% owner | Other | BUY | $2.37 | 751,945 | $1,780,079 | 2,108 | +100.0% |
| 2016-03-31 00:40 | 2016-03-22 | UAMY | UNITED STATES ANTIMONY CORP | parks daniel lyle | Officer - Chief Financial Officer | Primary Smelting & Refining of Nonferrous Metals | BUY | $2,405.00 | 12,500 | $30,062,500 | 64,500 | +24.0% |
| 2016-03-29 18:39 | 2016-03-29 | CRVS | Corvus Pharmaceuticals, Inc. | Gould Terry P | Director, 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 200,000 | $3,000,000 | 736,033 | +37.3% |
| 2016-03-29 19:16 | 2016-03-24 | AGC | N/A | Saba Capital Management, L.P. | 10% owner | Other | BUY | $5.29 | 208,234 | $1,101,870 | 3,403,611 | +6.5% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.